Subsidiary of ApicHope Pharmaceutical Group (300723.SZ) obtains registration certificate for amlodipine benzenesulfonate tablets
Announcement of Yiping Hong (300723.SZ): The company's wholly-owned subsidiary, Guangzhou Yiping Hong Pharmaceutical Co., Ltd., recently received a notification from the country...
ApicHope Pharmaceutical Group (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou ApicHope Pharmaceutical Group Pharmaceutical Co., Ltd., recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the amlodipine besylate tablet. Indications for amlodipine besylate tablets include: hypertension and coronary artery disease (CAD).
Related Articles

Hon Hai's Q1 revenue increased by 29.68% compared to the same period last year. It is expected that Q2 sales will increase both sequentially and year-on-year.

EB SECURITIES: Shanghai Electric Group (02727) continues to make breakthroughs in emerging industries such as 25 years of nuclear fusion and Siasun Robot & Automation. We maintain a "buy" rating.

Guosheng Macro: Jobs in the United States show signs of improvement in March, but underlying worries remain.
Hon Hai's Q1 revenue increased by 29.68% compared to the same period last year. It is expected that Q2 sales will increase both sequentially and year-on-year.

EB SECURITIES: Shanghai Electric Group (02727) continues to make breakthroughs in emerging industries such as 25 years of nuclear fusion and Siasun Robot & Automation. We maintain a "buy" rating.

Guosheng Macro: Jobs in the United States show signs of improvement in March, but underlying worries remain.

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


